Pirfenidone
- Product NDC
- 76282-716
- 11-digit product format
- 762820716
- Labeler code
- 76282
- Product ID
- 76282-716_3449172d-fe07-4924-ad05-89b854600aeb
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Pirfenidone
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Labeler
- EXELAN PHARMACEUTICALS INC.
- Application
- ANDA212078
- Marketing category
- ANDA
- Marketing start
- 2022-08-02
- Substance
- PIRFENIDONE
- Active strength
- 801 mg/1
- Pharmacologic classes
- Pyridone [EPC], Pyridones [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Pirfenidone
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PIRFENIDONE | 801 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | D7NLD2JX7U |
| Rxcui | 1868014, 1868018 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 76282-716-27 | Pirfenidone | 270 in 1 BOTTLE | TABLET, COATED | 270 | | 2 |
| 76282-716-90 | Pirfenidone | 90 in 1 BOTTLE | TABLET, COATED | 90 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 76282-716 | PIRFENIDONE TABLET, COATED [EXELAN PHARMACEUTICALS INC.] | 2 | Current NDC, Legacy NDC, 2 package rows | 20220811_c171e4af-1619-4712-958f-ef96adfede37.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 76282-716-27 | 76282071627 | 270 TABLET, COATED in 1 BOTTLE (76282-716-27) | 2022-08-02 | 0000-00-00 | No | No | Current |
| 76282-716-90 | 76282071690 | 90 TABLET, COATED in 1 BOTTLE (76282-716-90) | 2022-08-02 | 0000-00-00 | No | No | Current |